Anumana vs Navina
Navina is sold to value-based primary care groups, and KLAS comments describe a per-member-per-month fee. It reconciles EHR, HIE and claims data into chart summaries, suggests HCC codes at the visit and tracks care gaps. Epic, athenahealth and Veradigm are named on its homepage, and Privia Health and Agilon Health appear among its logos. The KLAS comments are unrated excerpts. One reads "Our physicians really like Navina", another "Navina's support overpromises and underdelivers". The vendor-published Phyx report claims 40% less chart review time on complex visits.
A hospital's cardiology unit is where Anumana lands. The vendor says its ECG-AI deploys within EHRs, names no EHR, and says it is eligible for reimbursement today.
A health system with both primary care and cardiology could buy each for its own department. A group paid on risk adjustment would look at Navina first.
Decision support · Reviewed November 2, 2026
When to pick each one
Anumana
- Cleared ECG-AI for heart conditions
- Vendor says it deploys within EHRs
Navina
- Epic, athenahealth and Veradigm named on homepage
- HIPAA, SOC 2 and ISO 27001 badges
Score
Each row shows points earned of points available under the published rubric.
Anumana
37of 100
Navina
36of 100
| Dimension | Anumana | Navina | Difference |
|---|---|---|---|
| FDA clearance | 12 / 12 | 0 / 12 | +12 |
| HIPAA / SOC2 / BAA | 0 / 10 | 10 / 10 | -10 |
| EHR integrations (count) | 0 / 5.6 | 1.7 / 5.6 | -1.7 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 3.4 / 4.8 | -3.4 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 14.7 / 21 | 0 / 21 | +14.7 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 3 / 12 | 8.4 / 12 | -5.4 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 0 / 6 | 6 / 6 | -6 |
Scroll horizontally to see every column.
Pricing
Anumana
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. The pricing page returns 404; the site offers a demo request only. |
Navina
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Anumana
FDA decisions
K253801 (opens in new tab)510(k)2026-04-07
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm (1040)
K252360 (opens in new tab)510(k)2026-03-28
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm (1020)
K250652 (opens in new tab)510(k)2025-07-28
ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010)
K232699 (opens in new tab)510(k)2023-09-28
Low Ejection Fraction AI-ECG Algorithm
Peer-reviewed
3 PubMed records name Anumana.
- A Pragmatic Trial Evaluating the Impact of the Anumana Clinical Decision Support Tool for Guideline-Directed Management of Heart Failure (ACT-HF): Clinical trial design and methods. (opens in new tab)
- Comment on "A pragmatic trial evaluating the impact of the anumana clinical decision support tool for guideline-directed management of heart failure (ACT-HF): Clinical trial design and methods". (opens in new tab)
- Identification and risk stratification of coronary disease by artificial intelligence-enabled ECG. (opens in new tab)
Navina
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Anumana | Navina |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | athenahealth, Epic, Veradigm |
| Founded | n/a | 2018 |
| HQ | US | n/a |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.


